Its importance for maintaining B-cell development and integrity has been underlined by studying murine knockout models (4) and the identification of human NFKB1 and NFKB2 gene defects with B-cell deficiency-related clinical manifestations initially classified as common variable immunodeficiencies (CVIDs) (5–18). This evidence concerns the gene NFKB2 and common variable immunodeficiency.